Secarna Pharmaceuticals Presents Data at OTS Showcasing Unique Characteristics and Factors with a Role in the Activity and Side Effect Profile of LNA-Modified ASOs pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): ConferenceSecarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs 25.10.2023 / 15:00 CET/CESTThe issuer is solely responsible for the content of t.
Secarna Pharmaceuticals Presents Data at OTS Showcasing Unique Characteristics and Factors with a Role in the Activity and Side Effect Profile of LNA-Modified ASOs dallassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallassun.com Daily Mail and Mail on Sunday newspapers.
Secarna Pharmaceuticals GmbH & Co KG: Secarna Pharmaceuticals to Present Two Posters Showcasing the Innovation Potential of the LNAplus Platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): ConferenceSecarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society 17.10.2023 / 14:00 CET/CESTThe issuer is solely responsible for the.